Celgene

CELG

CELG
Celgene Stock Quote
$95.42 -$0.09 -0.1%
BATS BZX Real Time Price as of May 17, 2019, 4:30 p.m. View Interactive CELG Charts

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

News & Analysis: Celgene

The Fool has written over 900 articles on Celgene.

All

Market Moves

Podcasts

Earnings

Celgene's Final Earnings Report?

Depending on when in the third quarter its deal with Bristol-Myers Squibb closes, this could be the last report of the beloved big biotech.











Interactive Chart